company background image
1762 logo

Chunghwa Chemical Synthesis & Biotech TWSE:1762 Stock Report

Last Price

NT$52.20

Market Cap

NT$4.0b

7D

-0.4%

1Y

-32.5%

Updated

25 Jul, 2024

Data

Company Financials +

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

TWSE:1762 Stock Report

Market Cap: NT$4.0b

1762 Stock Overview

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

1762 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends1/6

Rewards

Risk Analysis


Chunghwa Chemical Synthesis & Biotech Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Chunghwa Chemical Synthesis & Biotech
Historical stock prices
Current Share PriceNT$52.20
52 Week HighNT$78.20
52 Week LowNT$43.60
Beta0.77
11 Month Change3.78%
3 Month Change16.26%
1 Year Change-32.47%
33 Year Change-14.98%
5 Year Change59.15%
Change since IPO-30.40%

Recent News & Updates

Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Dividend Is Being Reduced To NT$0.80

Jul 12
Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Dividend Is Being Reduced To NT$0.80

Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 04
Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Recent updates

Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Dividend Is Being Reduced To NT$0.80

Jul 12
Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Dividend Is Being Reduced To NT$0.80

Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 04
Chunghwa Chemical Synthesis & Biotech's (TWSE:1762) Sluggish Earnings Might Be Just The Beginning Of Its Problems

A Look At The Intrinsic Value Of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

Apr 01
A Look At The Intrinsic Value Of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s (TPE:1762) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 04
Chunghwa Chemical Synthesis & Biotech Co., Ltd.'s (TPE:1762) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

What To Know Before Buying Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762) For Its Dividend

Jan 28
What To Know Before Buying Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762) For Its Dividend

Should You Rely On Chunghwa Chemical Synthesis & Biotech's (TPE:1762) Earnings Growth?

Jan 02
Should You Rely On Chunghwa Chemical Synthesis & Biotech's (TPE:1762) Earnings Growth?

The Chunghwa Chemical Synthesis & Biotech (TPE:1762) Share Price Is Up 131% And Shareholders Are Boasting About It

Dec 06
The Chunghwa Chemical Synthesis & Biotech (TPE:1762) Share Price Is Up 131% And Shareholders Are Boasting About It

Shareholder Returns

1762TW PharmaceuticalsTW Market
7D-0.4%-3.5%-3.8%
1Y-32.5%13.3%31.9%

Return vs Industry: 1762 underperformed the TW Pharmaceuticals industry which returned 13.3% over the past year.

Return vs Market: 1762 underperformed the TW Market which returned 31.9% over the past year.

Price Volatility

Is 1762's price volatile compared to industry and market?
1762 volatility
1762 Average Weekly Movement2.7%
Pharmaceuticals Industry Average Movement4.5%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.6%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 1762 has not had significant price volatility in the past 3 months.

Volatility Over Time: 1762's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1964n/aChung-Hsin Huangwww.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, anti-virus, immunomodulating agents, and other products, as well as peptide drugs.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Fundamentals Summary

How do Chunghwa Chemical Synthesis & Biotech's earnings and revenue compare to its market cap?
1762 fundamental statistics
Market capNT$4.05b
Earnings (TTM)NT$126.22m
Revenue (TTM)NT$1.57b

32.1x

P/E Ratio

2.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1762 income statement (TTM)
RevenueNT$1.57b
Cost of RevenueNT$1.05b
Gross ProfitNT$525.90m
Other ExpensesNT$399.68m
EarningsNT$126.22m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.63
Gross Margin33.44%
Net Profit Margin8.03%
Debt/Equity Ratio39.0%

How did 1762 perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

49%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.